Covid shielder says new AstraZeneca medicine Evusheld will let him 'resume normal life'

0
27


Evusheld has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to prevent COVID-19 in people whose immune response is poor.

Tayler has a disease called primary immune deficiency (PID), a rare genetic disorder of the immune system which means the immune system does not function properly.

Without a functioning immune system, people with the condition are at risk of “debilitating” and chronic diseases–including the Epstein-Barr virus which causes glandular fever.

While many people have celebrated the easing of the lockdown, Tayler has continued to isolate at his home while his wife, who is required to go into the office, has left.

“I’m pretty much stuck at home. I’ve barely socialised. And it’s been pretty tough on my wife. Unfortunately, our marriage is pretty much broken down as a result.

READ MORE: Scientists develop ‘dementia calculator’ to predict your risk within the next five years



LEAVE A REPLY

Please enter your comment!
Please enter your name here